[e-drug] Open Source for Global Health R&D Magic Bullet or Mirage?

E-DRUG: Open Source for Global Health R&D Magic Bullet or Mirage?
-------------------------------------------------------

Open Source for Global Health R&D Magic Bullet or Mirage?
New R4D Report on Scientific Collaborations for Neglected Disease R&D

Dear Colleagues,

I would like to invite your feedback on the consultation draft of R4D’s
Center for Global Health R&D Policy Assessment report, "Open Source for
Neglected Diseases: Challenges and Opportunities <http://healthresearchpolicy.org/assessments/draft&gt;

The landscaping report explores the concept of open source collaboration for
global health R&D and discusses its potential to lower costs and R&D time
frames, increase collaboration, and build a knowledge commons. This report
describes existing open source initiatives and looks at ways in which the
global health R&D community might further investigate open source approaches
and test their potential.

The consultation draft will be available for public comment until *March 4,
2011*. Your feedback is important to our assessment process. We invite you
to post your comments to our website
<http://healthresearchpolicy.org/assessments/open-source-neglected-diseases-challenges-and-opportunities&gt;\. [Repair link if it breaks]

You are also welcome to send a more detailed response to the authors, R4D
consultants Hassan Masum and Rachelle Harris at
<policyassessment@resultsfordevelopment.org>

We will soon be posting another of our Center’s consultation drafts on the
potential impact of a tax credit for global health R&D in the U.S.

You can find the latest information on all of our assessments on our
website, www.healthresearchpolicy.org

Thanks for your help,

Robert Hecht

Results for Development Institute (R4D)
1875 Connecticut Avenue, NW
Suite 1210
Washington, DC 20009
+1-202-470-5711
www.resultsfordevelopment.org
Ben Thomas <bthomas@resultsfordevelopment.org>